SEARCH

SEARCH BY CITATION

References

  • 1
    Mathews R., Hall W., Carter A. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction 2012; 107: 20692074.
  • 2
    Gollust S. E., Gordon E. S., Zayac C., Griffin G., Christman M. F., Pyeritz R. E. et al. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics 2012; 15: 2230.
  • 3
    Su Y., Howard H. C., Borry P. Users’ motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. J Commun Genet 2011; 2: 135146.
  • 4
    Ormond K. E., Hudgins L., Ladd J. M., Magnus D. M., Greely H. T., Cho M. K. Medical and graduate students’ attitudes toward personal genomics. Genet Med 2011; 13: 400408.
  • 5
    Neumann P. J., Cohen J. T., Hammitt J. K., Concannon T. W., Auerbach H. R., Fang C. et al. Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ 2012; 21: 238251.
  • 6
    Bloss C. S., Schork N. J., Topol E. J. Effect of direct-to-consumer genome wide profiling to assess disease risk. N Engl J Med 2011; 364: 524534.
  • 7
    Marteau T. M., French D. P., Griffin S. J., Prevost A. T., Sutton S., Watkinson C. et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev 10:CD007275.
  • 8
    Keller M. A., Gordon E. S., Gharani N., Sill C. J., Schmidlen T. J., Mintzer J. et al. Coriell personalized medicine collaborative®: a prospective study of the utility of personalized medicine. Pers Med 2010; 7: 301317.
  • 9
    Nuffield Council on Bioethics. Medical Profiling and Online Medicine: the Ethics of ‘Personalised Healthcare’ in a Consumer Age. London; Nuffield Council on Bioethics; 2010.
  • 10
    Caulfield T. DTC genetic testing: pendulum swings and policy paradoxes. J Clin Genet 2012; 81: 46.
  • 11
    Caulfield T. Direct-to-consumer testing: if consumers are not anxious, why are policymakers? J Hum Genet 2011; 130: 2325.
  • 12
    Navigenics. New England Journal of Medicine Publishes Initial Data on Study Examining Impact of Personal Genomics. 2011–01–12. URL: http://www.navigenics.com/visitor/about_us/press/releases/NEJM_SGHI_011211/ (accessed: 2 June 2012; archived by WebCite® at http://www.webcitation.org/687fxIrAe)